DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB16688
| null |
Reproxalap
|
916056-79-6
|
F0GIZ22IJH
|
ADX 102 | ADX102 | ALD-102 | NS-2 | Reproxalap
|
GUHFUVLKYSQIOQ-UHFFFAOYSA-N
|
DB16689
| null |
Tengonermin
|
1960461-99-7
|
2YQ0811D7K
|
NGR-hTNF | Tengonermin
| null |
DB16690
| null |
Tegoprazan
|
942195-55-3
|
W017G7IF4S
|
CJ-12420 | IN-A001 | K-CAB | LXI-15028 | RQ-00000004 | Tegoprazan
|
CLIQCDHNPDMGSL-HNNXBMFYSA-N
|
DB16691
| null |
Nirmatrelvir
|
2628280-40-8
|
7R9A5P7H32
| null |
LIENCHBZNNMNKG-OJFNHCPVSA-N
|
DB16692
| null |
Axalimogene filolisbac
| null |
NY7PTD1862
|
Adxs hpv | Adxs-hpv | Live, attenuated listeria monocytogenes bacteria, expressing human papilloma virus type 16-e7 tumor antigen | Raligize
| null |
DB16693
| null |
Insulin icodec
|
1188379-43-2
|
P7YU3ED05N
|
Insulin 287 | Insulin icodec
| null |
DB16694
| null |
Pegcetacoplan
|
2019171-69-6
|
TO3JYR3BOU
|
Pegcetacoplan
| null |
DB16695
| null |
Amivantamab
|
2171511-58-1
|
0JSR7Z0NB6
|
amivantamab-vmjw
| null |
DB16697
| null |
Glutazumab
| null | null | null | null |
DB16698
| null |
Neihulizumab
| null |
615637S5PE
| null | null |
DB16699
| null |
Vutrisiran
|
1867157-35-4
|
GB4I2JI8UI
|
Votrisiran | Vutrisiran
| null |
DB16700
| null |
Runcaciguat
|
1402936-61-1
|
5EZ01YDT5S
|
Cyclopropylpropanoic acid | Runcaciguat
|
NCRMKIWHFXSBGZ-CNBXIYLPSA-N
|
DB16701
| null |
Plasminogen
|
9001-91-6
|
1EF190B6M7
|
1-glutamylplasminogen | Human plasminogen | Plasma trypsinogen | plasminogen, human-tvmh | Profibrinolysin
| null |
DB16702
| null |
Famprofazone
|
22881-35-2
|
HN0NCX453C
|
Famprofazone
|
GNUXVOXXWGNPIV-UHFFFAOYSA-N
|
DB16703
| null |
Belumosudil
|
911417-87-3
|
834YJF89WO
|
Belumosudil
|
GKHIVNAUVKXIIY-UHFFFAOYSA-N
|
DB16704
| null |
Durlobactam
|
1467829-71-5
|
PSA33KO9WA
|
(2S,5R)-2-CARBAMOYL-3-METHYL-7-OXO-1,6-DIAZABICYCLO(3.2.1)OCT-3-EN-6-YL SULFATE | Durlobactam | SULFURIC ACID, MONO((2S,5R)-2-(AMINOCARBONYL)-3-METHYL-7-OXO-1,6-DIAZABICYCLO(3.2.1)OCT-3-EN-6-YL) ESTER
|
BISPBXFUKNXOQY-RITPCOANSA-N
|
DB16705
| null |
Influenza A virus A/Tasmania/503/2020 IVR-221 (H3N2) antigen (formaldehyde inactivated)
| null |
V529EJB2CX
| null | null |
DB16706
| null |
Influenza A virus A/Wisconsin/588/2019 (H1N1) recombinant hemagglutinin antigen
| null |
GB6ADZ2ASN
| null | null |
DB16707
| null |
Gavorestat
|
2170729-29-8
|
6JLQ8K35KK
|
2-(4-Oxo-3-((5-(Trifluoromethyl)Benzo[D]Thiazol-2-Yl)Methyl)-3,4-Dihydrothieno[3,4-D]Pyridazin-1-Yl)Acetic Acid | AT-007 | AT007 | Gavorestat
|
ORQGHAJIWGGFJK-UHFFFAOYSA-N
|
DB16708
| null |
Cipaglucosidase alfa
|
2359727-71-0
|
4SED7F4BSG
|
Cipaglucosidase alfa | Recombinant human acid alpha-glucosidase optimized for high expression of mannose 6-phosphate
| null |
DB16709
| null |
Allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen
| null | null |
allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat | Viable and metabolically active allogeneic human NIKS keratinocytes and human dermal fibroblasts cellularized layered scaffold
| null |
DB16710
| null |
Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen
| null |
U1E9VSB2K2
|
Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine
| null |
DB16711
| null |
Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen
| null |
9WP2BC3I04
|
Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine
| null |
DB16712
| null |
Corynebacterium diphtheriae CRM197 protein
|
1272033-67-6
|
08VC9WC084
|
Corynebacterium diphtheriae CRM-197 protein | CRM 197 | CRM-197 | CRM197 | Diphtheria CRM197 protein | Diphtheria toxin mutant CRM197
| null |
DB16713
| null |
Streptococcus pneumoniae type 8 capsular polysaccharide diphtheria CRM197 protein conjugate antigen
| null |
ADR2S9OIF2
| null | null |
DB16714
| null |
Streptococcus pneumoniae type 10A capsular polysaccharide diphtheria CRM197 protein conjugate antigen
| null |
N47C1SHV0F
| null | null |
DB16715
| null |
Streptococcus pneumoniae type 11A capsular polysaccharide diphtheria CRM197 protein conjugate antigen
| null |
RDA5AKV23D
| null | null |
DB16716
| null |
Streptococcus pneumoniae type 12F capsular polysaccharide diphtheria CRM197 protein conjugate antigen
| null |
T6O227OX7Q
| null | null |
DB16717
| null |
Streptococcus pneumoniae type 15B capsular polysaccharide diphtheria CRM197 protein conjugate antigen
| null |
H8Q6FRO6DY
| null | null |
DB16718
| null |
Influenza A virus A/Tasmania/503/2020 (H3N2) live (attenuated) antigen
| null |
R4YW6332PS
| null | null |
DB16719
| null |
Influenza A virus A/Victoria/1/2020 (H1N1) live (attenuated) antigen
| null |
U3PQ457K3F
| null | null |
DB16720
| null |
Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen (UV, formaldehyde inactivated)
| null |
34C49NV47P
| null | null |
DB16721
| null |
Influenza A virus A/Tasmania/503/2020 IVR-221 (H3N2) antigen (UV, formaldehyde inactivated)
| null |
2945QC7YF6
| null | null |
DB16722
| null |
Influenza A virus A/Victoria/2570/2019 IVR-215 (H1N1) antigen (propiolactone inactivated)
| null |
6F59DL4EET
| null | null |
DB16723
| null |
Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (propiolactone inactivated)
| null |
Y9CJF75RBV
| null | null |
DB16724
| null |
Influenza A virus A/Tasmania/503/2020 (H3N2) recombinant hemagglutinin antigen
| null |
8TWH32Y7WK
| null | null |
DB16725
| null |
Influenza A virus A/Cambodia/e0826360/2020 IVR-224 (H3N2) antigen (formaldehyde inactivated)
| null |
YY2TBU8YQS
| null | null |
DB16726
| null |
Influenza A virus A/Tasmania/503/2020 (H3N2) antigen (MDCK cell derived, propiolactone inactivated)
| null |
6ER9J3GB63
| null | null |
DB16727
| null |
Influenza A virus A/Washington/19/2020 (H1N1) antigen (MDCK cell derived, propiolactone inactivated)
| null |
3YN85TU9MJ
| null | null |
DB16728
| null |
Lirentelimab
|
2283348-97-8
|
SWS48LJU3T
|
Antolimab | IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SIALIC ACID-BINDING IG-LIKE LECTIN 8 (SIALOADHESIN FAMILY MEMBER 2, SIGLEC-8, SAF-2))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-450) (VH (HOMO SAPIENS IGHV3-66*01 (79%) (IGHD)-IGHJ5*01 (91%)/MUS | IMMUNOGLOBULIN G1, ANTI-(HUMAN SIALIC ACID-BINDINGE IG-LIKE LECTIN 8) (HUMAN-MUS MUSCULUS MONOCLONAL AK002 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AK002 .KAPPA.-CHAIN, DIMER | Lirentelimab | MONOCLONAL ANTIBODY AK002 | Recombinant humanized, non-fucosylated IgG1 anti-Siglec-8 monoclonal antibody
| null |
DB16729
| null |
Favezelimab
|
2231068-83-8
|
H1396W7D1H
|
Favezelimab | Mavezelimab
| null |
DB16730
| null |
Enibarcimab
|
2305638-98-4
|
K2IB8MBP1A
|
Adrecizumab | Enibarcimab
| null |
DB16731
| null |
Dextilidine
|
32447-90-8
|
2728MV084C
|
Dextilidina | Dextilidine | Dextilidinum
|
WDEFBBTXULIOBB-WBVHZDCISA-N
|
DB16732
| null |
Tisotumab vedotin
|
1418731-10-8
|
T41737F88A
|
HuMax-TF-ADC | Tisotumab vedotin | tisotumab vedotin-tftv
| null |
DB16733
| null |
Rimtuzalcap
|
2167246-24-2
|
USO2D5J77R
|
N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine | Rimtuzalcap
|
OVLIDRAJVMUEMC-UHFFFAOYSA-N
|
DB16734
| null |
STG-001
| null |
IK88NC17OD
| null |
WSFKMLQSYRCAQE-UHFFFAOYSA-N
|
DB16735
| null |
PAT-1251
|
2098884-52-5
|
Y3HMF6G24B
| null |
ODGXXYXJORZPHE-ZIAGYGMSSA-N
|
DB16736
| null |
Allogeneic processed thymus tissue
| null |
XD66YK3YY3
|
Allogeneic processed thymus tissue-agdc | Allogeneic thymocyte depleted processed thymus tissue slices | Allogeneic thymocyte-depleted thymus tissue-agdc | Allogenic thymocyte-depleted thymus tissue-agdc
| null |
DB16737
| null |
MM3122
| null | null |
Ac-GQFR-kbt
|
ZEPMYXYJCBQSLH-VABKMULXSA-N
|
DB16738
| null |
Ciltacabtagene autoleucel
| null |
0L1F17908Q
|
Autologous bi-epitope BCMA-targeted CAR T-cells | Ciltacabtagene autoleucel
| null |
DB16739
| null |
MK-886
|
118414-82-7
|
080626SQ8C
| null |
QAOAOVKBIIKRNL-UHFFFAOYSA-N
|
DB16740
| null |
Prolgolimab
|
2093956-19-3
|
W05CP6IT8R
| null | null |
DB16741
| null |
Bortezomib D-mannitol
|
444576-08-3
|
P2AWN9VSQ6
|
Bortezomib D-mannitol ester | Bortezomib D-mannitol symmetrical ester | Bortezomib mannitol boronic ester
|
QDMRNLRJDHCHLB-DNNBANOASA-N
|
DB16742
| null |
RP-67580
|
135911-02-3
|
49U9M41BGY
| null | null |
DB16743
| null |
Nolpitantium chloride
|
153050-21-6
|
22O6XI63E0
| null | null |
DB16744
| null |
CP-96345
|
132746-60-2
|
W22ILA2I52
| null | null |
DB16745
| null |
PXT 3003
|
1467047-91-1
| null | null |
WRUIDZKNUAHKTR-UHFFFAOYSA-N
|
DB16746
| null |
Elivaldogene autotemcel
| null |
KUM75TD6SG
|
eli-cel
| null |
DB16747
| null |
Penpulimab
|
2350298-92-7
|
IBS1BZ4E4I
|
Penpulimab
| null |
DB16748
| null |
Apamistamab iodine I-131
|
2097132-02-8
|
71RR81V666
|
131I-BC8 monoclonal antibody (Anti-CD45 murine monoclonal antibody radiolabeled with 131I | Immunoglobulin G1, anti-(human CD45 antigen) (mus musculus monoclonal BC8 gamma1-chain), disulfide with mus musculus monoclonal BC8 kappa-chain, dimer, labeled with iodine-131 | Iodine (131i) apamistamab | Iodine I 131 apamistamab
| null |
DB16750
| null |
THE-630
| null | null | null | null |
DB16751
| null |
RLY-2608
| null | null | null | null |
DB16752
| null |
Cipatinib
| null | null | null | null |
DB16753
| null |
SB719125
| null | null |
dHER2 + AS15 ASCI | dHER2 ASCI
| null |
DB16754
| null |
TPMPA
|
182485-36-5
|
TR7I0800L2
|
(1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid | P-Methyl-P-(1,2,3,6-tetrahydro-4-pyridinyl)phosphinic acid | Phosphinic acid, P-methyl-P-(1,2,3,6-tetrahydro-4-pyridinyl)-
|
MFUKVPOVVKKLRQ-UHFFFAOYSA-N
|
DB16755
| null |
Bebtelovimab
|
2578319-11-4
|
8YL4SYR6CU
|
Bebtelovimab
| null |
DB16756
| null |
Ivarmacitinib
|
1445987-21-2
|
K6K4B9Z5TV
|
Ivarmacitinib
|
DNBCBAXDWNDRNO-GDNZZTSVSA-N
|
DB16757
| null |
Plant-based virus-like particles, recombinant, adjuvanted COVID-19 vaccine
| null | null |
Covifenz | Recombinant SARS-CoV-2 spike (S)-protein virus-like particle
| null |
DB16758
| null |
BAY-876
|
1799753-84-6
| null |
BAY 876 | BAY876
|
BKLJDIJJOOQUFG-UHFFFAOYSA-N
|
DB16759
| null |
Fasentin
|
392721-37-8
| null | null |
GNYIJZMBLZXJEJ-UHFFFAOYSA-N
|
DB16760
| null |
Lavendustin b
|
125697-91-8
|
7T53EGQ52Z
| null |
RTYOLBQXFXYMKY-UHFFFAOYSA-N
|
DB16761
| null |
STF-31
|
724741-75-7
| null |
STF 31 | STF31
|
NGQPRVWTFNBUHA-UHFFFAOYSA-N
|
DB16762
| null |
Tyrphostin B44
|
133550-32-0
| null |
AG 527 | AG527 | Tyrphostin AG 527 | Tyrphostin B-44 | Tyrphostin B44, (-) enantiomer | Tyrphostin B44(-)
|
UMGQVUWXNOJOSJ-KMHUVPDISA-N
|
DB16763
| null |
Tyrphostin AG 835
|
133550-37-5
| null |
Tyrphostin Ag-835 | Tyrphostin B44, (+) enantiomer | Tyrphostin B50
|
UMGQVUWXNOJOSJ-DGGAMASNSA-N
|
DB16764
| null |
WZB-117
|
1223397-11-2
| null |
WZB 117 | WZB117
|
FRSWCCBXIHFKKY-UHFFFAOYSA-N
|
DB16765
| null |
3-O-Methyl-d-glucose
|
146-72-5
|
48DU64I6O5
|
3-Methyl-D-glucose | 3-Methylglucose | 3-O-Methylglucose | Methylglucose | O(3)-methyl-D-glucose
|
RMTFNDVZYPHUEF-XZBKPIIZSA-N
|
DB16766
| null |
Cytochalasin B
|
14930-96-2
|
3CHI920QS7
|
Cytochalasin-B | Phomin
|
GBOGMAARMMDZGR-TYHYBEHESA-N
|
DB16767
| null |
Isorhamnetin
|
480-19-3
|
07X3IB4R4Z
|
3-Methylquercetin | 3-Methylquercetine | 3'-Methoxy-3,4',5,7-tetrahydroxyflavone | 3'-Methoxyquercetin | 3'-Methylquercetin | 3'-O-Methylquercetin | Isorhamnetol | Quercetin 3'-methyl ether
|
IZQSVPBOUDKVDZ-UHFFFAOYSA-N
|
DB16768
| null |
Lavendustin A
|
125697-92-9
|
3Y0G32G2RV
| null |
ULTTYPMRMMDONC-UHFFFAOYSA-N
|
DB16769
| null |
Methyl 2,5-dihydroxycinnamate
|
63177-57-1
|
6LF2DGK4XM
|
2,4-Dihydroxymethylcinnamate | Methyl-2,5-dihydroxycinnamate
|
BQCNSTFWSKOWMA-GORDUTHDSA-N
|
DB16770
| null |
Morin
|
480-16-0
|
8NFQ3F76WR
|
2-(2,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4h-1-benzopyran-4-one | 2',3,4',5,7-Pentahydroxyflavone | Al-Morin | Aurantica | C.I. Natural yellow 8 | Calico Yellow
|
YXOLAZRVSSWPPT-UHFFFAOYSA-N
|
DB16771
| null |
Phlorizin
|
60-81-1
|
CU9S17279X
|
Floridzin | Phloretin 2'-glucoside | Phlorhizin | Phloridzin | Phloridzosid | Phlorizoside | Phlorrhizen | Phlorrhizin
|
IOUVKUPGCMBWBT-QNDFHXLGSA-N
|
DB16772
| null |
Rhamnetin
|
90-19-7
|
71803L5F4S
|
7-Methoxyquercetin | 7-Methylquercetin | 7-O-Methylquercetin | beta-Rhamnocitrin | Quercetin 7-methyl ether
|
JGUZGNYPMHHYRK-UHFFFAOYSA-N
|
DB16773
| null |
Tyrphostin AG 555
|
133550-34-2
| null |
AG 555 | AG-555 | Tyrphostin AG 555 | Tyrphostin AG-555 | Tyrphostin B-46 | Tyrphostin B46
|
GSQOBTOAOGXIFL-LFIBNONCSA-N
|
DB16774
| null |
Tyrphostin B48
|
133550-35-3
| null |
AG 494 | AG-494 | Alpha-Cyano-(3,4-dihydroxy)-N-phenylcinnamide | Tyrphostin AG-494
|
HKHOVJYOELRGMV-XYOKQWHBSA-N
|
DB16775
| null |
Tyrphostin B56
|
149092-35-3
| null |
AG 556 | AG-556 | AG556 | Tyrphostin AG-556 | Tyrphostin AG556
|
GWCNJMUSWLTSCW-SFQUDFHCSA-N
|
DB16776
| null |
Tyrphostin AG 879
|
148741-30-4
| null |
AG 879 | AG-879 | AG879 | Tyrphostin AG-879 | Tyrphostin AG879
|
XRZYELWZLNAXGE-KPKJPENVSA-N
|
DB16778
| null |
Lutetium Lu-177 vipivotide tetraxetan
|
1703749-62-5
|
G6UF363ECX
|
177Lu-PSMA-617
| null |
DB16779
| null |
Resamirigene bilparvovec
|
2085240-27-1
|
F6LOJ6ER4S
|
DNA (synthetic adeno-associated virus 8 vector AT132 human myotubularin cDNA-specifying) | Non-replicating adeno-associated viral vector, serotype 8, expressing human myotubularin gene
| null |
DB16780
| null |
Eladocagene exuparvovec
|
2098615-91-7
|
S51J6N56M7
|
Eladocagene exuparvovec
| null |
DB16781
| null |
Lenadogene nolparvovec
|
1640969-63-6
|
X0R16875YD
|
Lenadogene nolparvovec
| null |
DB16782
| null |
Lanacogene vosiparvovec
|
1939139-26-0
|
L7D6JMC51Y
|
Lanacogene vosiparvovec
| null |
DB16783
| null |
Fidanacogene elaparvovec
|
1954659-47-2
|
413EU9081Y
|
Fidanacogene elaparvovec
| null |
DB16784
| null |
Rebisufligene etisparvovec
|
1966978-67-5
|
V28L3Q0LVZ
|
ABO-102 | Rebisufligene etisparvovec | scAAV9.U1a.hSGSH | UX111
| null |
DB16785
| null |
Volrubigene ralaparvovec
|
2092457-20-8
|
8WI5RJ8D9V
|
Non-replicating recombinant adeno-associated viral vector, serotype 8, expressing the 1A1 isoform of the bilirubin-uridine diphosphate glucuronosyltransferase gene | Volrubigene ralaparvovec
| null |
DB16786
| null |
Inlezifigene civaparvovec
|
2143578-31-6
|
87RN2MR2FP
|
Inlezifigene civaparvovec
| null |
DB16787
| null |
Ranuzifigene civaparvovec
|
2143578-32-7
|
52XT2AZD2N
|
Ranuzifigene civaparvovec
| null |
DB16788
| null |
Adlinacogene civaparvovec
|
2143579-02-4
|
J177M7U2XK
| null | null |
DB16789
| null |
Tefidsogene civaparvovec
|
2143580-10-1
|
2V7PRS3ISP
|
A RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS TYPE 2/6 (RAAV REP2-CAP6) VECTOR, WHICH CONTAINS A PROMOTER-LESS HUMAN IDURONATE 2-SULFATASE (HIDS) TRANSGENE CASSETTE, ENCODING PARTS OF EXON 1 PLUS EXONS 2-9 FROM HIDS AND A SPLICE ACCEPTOR SITE (SA) | Tefidsogene civaparvovec
| null |
DB16790
| null |
Devafidugene civaparvovec
|
2143580-11-2
|
50A8XX09WM
|
Devafidugene civaparvovec
| null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.